Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- MNDY -9.1%, TRMB -8.6%
Other news:
- ANTX -70.1% (to to voluntarily pause enrollment in Phase 3 Part of Phase 2/3 pivotal clinical trial evaluating Epetraborole)
- LRMR -42% (reports top-line data from Phase 2 dose exploration study from 25 mg and 50 mg Cohorts of nomlabofusp in patients with Friedreich's Ataxia)
- BIG -11.9% (seeking new financing to enhance liquidity according to Bloomberg)
- IVVD -7.6% (files for 37745998 share common stock offering by selling shareholders)
- APLD -6.9% (A complete power outage currently ongoing to materially affect revenues for FebQ)
- VUZI -5.4% (files for $300 mln mixed securities shelf offering)
- NVX -2.2% (Hosts Webcast with Dr. Chris Burns Following Panasonic Off-Take Announcement)
- FULT -1.5% (announces that CFO Mark McCollom has resigned; co names interim CFO)
- GSK -1.3% (despite receiving FDA Fast Track designation for bepirovirsen in chronic hepatitis B)
- DOV -1% (names CEO Richard Tobin to the additional role of Chairman of the Board)
Analyst comments:
- RIVN -3.1% (downgraded to Equal Weight from Overweight at Barclays)
- XPO -2.3% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- ROAD -1.3% (downgraded to Neutral from Outperform at Robert Baird)
- HSY -1% (downgraded to Underweight from Equal-Weight at Morgan Stanley)
- TFIN -1% (downgraded to Underweight from Neutral at Piper Sandler)